ArticleThe Lancet regional health. Europe2024
Impact of COVID-19 on total excess mortality and geographic disparities in Europe, 2020-2023: a spatio-temporal analysis.
Article in The Lancet regional health. Europe, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- In uncharted territory: managing the COVID-19 pandemic in Swedish regions and municipalities from a primary health care perspective.Scandinavian journal of primary health care · 2026Article
- Clinical Manifestations Associated with Pain in Nursing Students in Emerging Adulthood with Long COVID.Nursing reports (Pavia, Italy) · 2026Article
- Improving mortality rate estimation in 825 European cities: a linear mixed-effects modelling approach using Urban Audit data.European journal of public health · 2026Article
- Article
- COVID-19 Mortality in Swedish Intensive Care Units: A Multicenter Survival Analysis.Acta anaesthesiologica Scandinavica · 2026Article
- Mortality Patterns and Trends in Fars Province, Iran (2015-2024): A Retrospective Analysis of Death Records.Iranian journal of medical sciences · 2026Article
- Reassessing Early COVID-19 Strategies in East Asia: Insights From Japan and Korea.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2026Review
- COVID-19 vaccination coverage and the effect on regional disparities in morbidity and mortality among older people in Sweden, 2021-2023.Scandinavian journal of public health · 2026Article
- White by default: conceptual and methodological limits of binary white logic in global health equity research.Medicine, health care, and philosophy · 2026Article
- Excess Mortality as the Primary Mediator of COVID-19's Impact on Life Expectancy in Europe: A Multilevel Longitudinal Analysis of Regional Disparities.Medicina (Kaunas, Lithuania) · 2026Article
- Shifting to online and telephone bereavement support provision during the COVID-19 pandemic: A mixed methods study of bereavement service provider perspectives and lessons learnt for current practice.Palliative medicine · 2026Article
- Paid and unpaid productivity losses across 28 European countries due to excess deaths and COVID-19 deaths from 2020 to 2023.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Revealing institutional vulnerabilities in Nordic health systems through multidimensional scaling of COVID-19 mortality data.Scientific reports · 2026Article
- Increased Three-Year Mortality Was Observed During COVID-19 Pandemic Among Patients Discharged from the Acute Rehabilitation Ward After Acetabular and Femoral Fracture Surgery.Medicina (Kaunas, Lithuania) · 2026Observational
- Mortality risk during the COVID-19 pandemic is shaped by human development.BMC global and public health · 2026Article
- Mortality trends in the United States in recent years including provisional 2024 data.Preventive medicine reports · 2026Article
- Excess mortality in Europe estimated by EuroMOMO during the COVID-19 pandemic and previous influenza seasons.Nature communications · 2026Article
- Excess life-years and productive life-years lost in Poland through the COVID-19 pandemic and post-pandemic years.Archives of public health = Archives belges de sante publique · 2026Article
- Difference in excess mortality during the COVID-19 pandemic depending on marital status in Japan.PloS one · 2026Article
- Unmeasured confounding and misclassification in studies estimating vaccine effectiveness against hospitalisation and death using electronic health records (EHRs): an evaluation of a multi-country European retrospective cohort study.BMC medical research methodology · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: COVID-19 dramatically reshaped mortality across Europe. This study aimed to assess its impact on total mortality in European countries taking into consideration the relationship with selected country-level socioeconomic indicators, non-pharmaceutical interventions, and vaccine uptake. Methods: We obtained weekly mortality data from 2010 to 2023 from the Short-term Mortality Fluctuations data series, the annual population data from the United Nations archives, selected sociodemographic and economic indicators from the World Bank's database, the stringency index and the percentage of the population fully vaccinated from Our World in Data. A quasi-Poisson regression model trained on pre-pandemic years was used to estimate expected number of deaths in 2020-2023 in 29 European countries. Excess mortality was estimated using three different metrics: excess deaths (number), relative excess mortality (% different from expected deaths) and age-standardized excess death rate per 10,000 population. The relationship between socioeconomic indicators and excess mortality was evaluated using linear regression models, which included both linear and quadratic terms for the predictors to account for possible non-linear relationships. Findings: We estimated 1,642,586 excess deaths (95% confidence interval, CI: 1,607,161-1,678,010) across all countries over the four years (+8.0% compared to the expected number of deaths). Excess mortality was mainly concentrated in 2020-2022 (0.52 million excess deaths in 2020, 0.57 million in 2021 and 0.44 million in 2022), with no substantial excess (0.11 million) estimated for 2023. Over the period 2020-23, the highest number of excess deaths was estimated for Italy (227,736 deaths, +8.7%), Poland (223,735 deaths, +13.7%), and Germany (218,111 deaths, +5.6%), while the highest excesses in relative terms were in Bulgaria (72,328 deaths, +17.2%), Lithuania (23,813 deaths, +16.1%), and Slovakia (31,984 deaths, +14.9%). The age-standardised death rates ranged from 1.8 per 10,000 population in Sweden to 24.7 in Bulgaria. The percentage of the population living below the poverty line and the Gini index were significantly associated with an increased excess death rate, with Interpretation: The observed geographic disparities in total mortality excess across Europe can be related to differences in socioeconomic contexts, as well as to suboptimal vaccine uptakes in some countries. Funding: This research was supported by European Union (EU) funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT). The funding source had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.